Bruker

NEW YORK (GenomeWeb) — Researchers from Virginia Commonwealth University have developed a method of quantifying multiple nucleic acid targets in a single sample by combining low-cycle-number, target-specific PCR with atomic force microscopy.

NEW YORK (GenomeWeb) – Bruker said today that it has received clearance from the China Food and Drug Administration to sell its IVD MALDI Biotyper as a medical device for the identification of microorganisms isolated from human specimens.

BALTIMORE (GenomeWeb News) – While triple quads predominated at last year's American Society for Mass Spectrometry annual meeting, high-resolution instruments were the focus of this year's gathering with several vendors launching new high-end QTOF or Q-Orbitrap machines.

BALTIMORE (GenomeWeb) – With the launch of a new crop of high-resolution instruments at the American Society for Mass Spectrometry annual conference here this week, vendor

New Products: ASMS Focus

Premium

A number of vendors introduced new proteomics products at the American Society for Mass Spectrometry meeting in Baltimore this week. The following is a roundup of new offerings introduced at the conference.

NEW YORK (GenomeWeb) – Wells Fargo Securities today upgraded shares of Bruker to an Outperform rating and increased the price range on its stock after a Bruker official said the company plans to further restructure its Chemical and Applied Markets division and grow its presence in the clinical ma

NEW YORK (GenomeWeb News) – With first quarter results in for major life science mass spec vendors, a mixed picture has emerged as academic, government, and pharma spending delays, particularly in the US and China, countered stronger performance in European markets.

NEW YORK (GenomeWeb News) – Bruker reported after the close of the market Wednesday that its revenues in the first quarter were up 8 percent year over year, rising to $423.7 million from $393.4 million in Q1 2013.

NEW YORK (GenomeWeb) – Bruker said this week that it plans to make additional regulatory submissions for its MALDI Biotyper microbiology platform in the middle of this year.

With MALDI-TOF-based microbiology assays making significant headway in terms of clinical adoption, researchers and vendors have begun turning their sights on new applications for the technology.

Pages

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.